Global search for right cell type as a treatment modality for cardiovascular disease

Expert Opinion on Biological Therapy

Volumn 14, Issue 1, 2014, Pages 63-73

  Musa, Sabri ^a   Xin, Loo Zhang ^a   Govindasamy, Vijayendran ^b   Fuen, Foo Wei ^c   Kasim, Noor Hayaty Abu ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Hygieia Innovation Sdn Bhd ^*  (Malaysia)

^c Ampang Hospital   (Malaysia)

Author keywords

Cardiac regeneration; Cardiomyocytes; Myocardial infarction; Stem cells

Indexed keywords

ACUTE HEART INFARCTION; ADULT STEM CELL; ANGIOGENESIS; BIOLOGICAL FUNCTIONS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL TRANSDIFFERENTIATION; CELL TYPE; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; MEDICAL RESEARCH; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATION; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION; REGENERATION; TREATMENT OUTCOME;

EID: 84890206117     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2014.858694     Document Type: Review

References (61)

1. Leor J, Landa N, Cohen S. Renovation of the injured heart with myocardial tissue engineering. Expert Rev Cardiovasc Ther 2006;4:239-52
2. Sun L, Cui M, Wang Z, et al. Mesenchymal stem cells modified with Angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun 2007;357:779-84
3. Jessup M, Abraham WT, Casey DE, et al. Focused update: ACCF/ AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;119:1977-2016
4. Abu Kasim NH, Govindasamy V, Gnanasegaran N, et al. Unique molecular signatures influencing the biological function and fate of post-natal stem cells isolated from different sources. J Tissue Eng Regen Med 2012; Epub ahead of print
5. Rao M. The NIH and the regenerative medicine field. Regen Med 2012;7(2):129-31
6. Kajstura J, Leri A, Finato N, et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95(15):8801-5
7. Capi O, Gepstein L. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. J Control Release 2006;116(2):211-18
8. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010;107(7):913-22
9. Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006;14(6):840-50
10. Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 2007;4(Suppl 1):S21-6
11. Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012;10(3):244-58
12. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428(6983):668-73
13. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428(6983):664-8
14. Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines andpromote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94(5):678-85
15. Aranha AM, Zhang Z, Neiva KG, et al. Hypoxia enhances the angiogenic potential of human dental pulp cells. J Endod 2010;36(10):1633-7
16. Nagaya N, Fujii T, Iwase T, et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004;287(6):H2670-6
17. Gandia C, Arminan A, Garcia-Verdugo JM, et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 2008;26:638-45
18. McDevitt TC, Laflamme MA, Murry CE. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol 2005;39(6):865-73
19. Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J Mol Cell Cardiol 2012;52:1203-12
20. Wang M, Crisostomo PR, Herring C, et al. Human progenitor cells from bone marrow or adipose tissue produce VEGF,HGF, and IGF-I in response to TNF by a p38 MAPKdependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006;291(4):R880-4
21. Zhao R, Watt AJ, Battle MA, et al. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol 2008;317:614-19
22. Li H, Zuo S, He Z, et al. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival. Am J Physiol Heart Circ Physiol 2010;H1772-81
23. Menasché P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001;357(9252):279-80
24. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011;378:1847-57
25. Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomized phase 1 trial. Lancet 2012;379:895-904
26. Yu J, Thomson JA. Pluripotent stem cell lines. Genes Dev 2008;22:1987-97
27. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108(3):407-14
28. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-40
29. Passier R, Oostwaard DW, Snapper J, et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 2005;23:772-80
30. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in prosurvival factors enhance function of infracted rat hearts. Nat Biotechnol 2007;25(9):1015-24
31. Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stemcell- derived population. Nature 2008;453(7194):524-8
32. Min JY, Yang Y, Sullivan MF, et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003;125(2):361-9
33. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663-76
34. Yoshida Y, Yamanaka S. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol 2011;50(2):327-32
35. Efe JA, Hilcove S, Kim J, et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol 2011;13(3):215-22
36. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4(5):381-4
37. Freund C,Davis RP,Gkatzis K, et al. The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Neth Heart J 2010;18(1):51-4
38. Nelson TJ, Martinez-Fernandez A, Yamada S, et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009;120(5):408-16
39. Lin B, Kim J, Li Y, et al. High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc Res 2012;95(3):327-35
40. Oh Y, Wei H, Ma D, et al. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 2012;98(6):443-9
41. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142(3):375-86
42. D'Amario D, Fiorini C, Campbell PM, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 2011;108:857-61
43. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA 2007;104(35):14068-73
44. Bearzi C, Leri A, Lo Monaco F, et al. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci USA 2009;106:15885-90
45. Bu L, Jiang X, Martin-Puig S, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009;460(7251):113-17
46. He JQ, Vu DM, Hunt G, et al. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS One 2011;6(11):e27719
47. Nakamura S, Yamada Y, Katagiri W, et al. Stem cell proliferation pathways comparison between human exfoliated deciduous teeth and dental pulp stem cells by gene expression profile from promising dental pulp. J Endod 2009;35:1536-42
48. Haack-Sorensen M, Hansen SK, Hansen L, et al. Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion. Stem Cell Rev 2013;9(1):44-58
49. Liu L, Wei X, Ling J, et al. Expression pattern of Oct-4, Sox2, and c-Myc in the primary culture of human dental pulp derived cells. J Endod 2011;37:466-72
50. Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the wharton's jelly of the human umbilical cord. Stem Cells 2004;22:1330-7
51. Gaustad KG, Boquest AC, Anderson BE, et al. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun 2004;314(2):420-7
52. Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000;97:13625-30
53. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006;8:315-17
54. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potentialof adult human mesenchymal stem cells. Science 1999;284:143-17
55. Wong RS. Mesenchymal stem cell: angels or demons? J Biomed Biotechnol 2011;2011:459510
56. Labovsky V, Hofer EL, Feldman L, et al. Cardiomyogenic differentiation of human bone marrow mesenchymal cells: role of cardiac extract from neonatal rat cardiomyocytes. Differentiation 2010;79(2):93-101
57. Wang N, Zhang R, Wang SJ, et al. Vascular endothelial growth factor stimulates endothelial differentiation from mesenchymal stem cells via Rho/ myocardin-related transcription factor-A signaling pathway. Int J Biochem Cell Biol 2013;45(7):1447-56
58. Orlandi A, Pagani F, Avitabile D, et al. Functional properties of cells obtained from human cord blood CD34+ stem cells and mouse cardiac myocytes in coculture. Am J Physiol Heart Circ Physiol 2008;294(4):H1541-9
59. Arminan A, Gandia C, Garcia-Verdugo JM, et al. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol 2010;55(20):2244-53
60. Arminan A, Gandia C, Bartual M, et al. Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells Dev 2009;18(6):907-18
61. Rais Y, Zviran A, Geula S, et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013;502(7469):65-70